ACM
GSK icon

Advent Capital Management’s GSK GSK Stock Holding History

Advent Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,600
Closed -$170K – 506
2016
Q2 		$170K Buy
+1,600
New +$84.3K ﹤0.01% 387
2015
Q3 		– Sell
-200
Closed -$3K – 530
2015
Q2 		$3K Buy
+200
New +$11.3K ﹤0.01% 512

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Advent Capital Management's GSK Position: Q3 2019 in Review

Advent Capital Management sold out of GSK (GSK) in Q3 2019, closing a stake of 80,000 shares — an estimated $4M sold.

Advent Capital Management first reported a position in GSK in Q4 2014 and held it in 7 quarters. The position peaked at $4.53M in Q4 2014. 806 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

  • Advent Capital Management reported no remaining GSK position as of Q3 2019 after selling out during the quarter.
  • Advent Capital Management sold 80,000 GSK shares in Q3 2019, an estimated $4M.
  • Advent Capital Management first reported a position in GSK in Q4 2014 and held it in 7 quarters.
  • Advent Capital Management's GSK position peaked at $4.53M in Q4 2014.
  • 806 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on Advent Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.